Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05631990

A Study to Evaluate the Efficacy and Safety of AD-209

Conditions: Hypertension, Essential

Sex: All
Ages: 19 Years – 74 Years
Phase: PHASE2
Enrollment: 200
Sponsor: Addpharma Inc.

Location: Korea, Republic of

Summary

The purpose of this study is to evaluate the efficacy and safety of AD-209

Eligibility Criteria

Inclusion Criteria:Signed informed consentOther inclusions appliedExclusion Criteria:orthostatic hypotension with symptomOther exclusions applied

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05631990). StuddyBuddy aggregates publicly available trial information.